The genus Scedosporium comprises a group of filamentous fungi found ubiquitously in the environment. The two major human pathogens within this genus are S. apiospermum-the asexual state of Pseudallescheria boydii-and S. prolificans. Both histologically resemble Aspergillus species, with hyphae that are septated and branching at acute angles. Although Scedosporium infections can occur in immunocompetent persons, the overall incidence has increased over the last decade as a consequence of improved diagnostics and a growing immunosuppressed population (e.g., transplant, malignancy, acquired immunodeficiency syndrome). These organisms can cause systemic infection in immunocompromised hosts manifested as sinopulmonary, central nervous system, osteoarticular, ocular, endovascular, and lymphocutaneous disease. Dissemination may occur hematogenously or contiguously, with high associated mortality (>75%). Scedosporium species are known to be largely resistant to traditional antifungals such as amphotericin B; however, treatment with newer triazoles, such as voriconazole, appears to be more efficacious.
KEYWORDS
Scedosporium - annellides - hyphomycoses - emerging opportunistic infections - multiantifungal drug resistance
REFERENCES
-
1 Anaissie E J, McGinnis M R, Pfaller M A. Hyalohyphomycoses. In: Clinical Mycology. Churchill Livingstone Elsevier 2003: 309
-
2
Matsumoto T, Ajello L, Matsuda T, Szaniszlo P J, Walsh T J.
Developments in hyalohyphomycosis and phaeohyphomycosis.
J Med Vet Mycol.
1994;
32(suppl 1)
329-349
-
3 Ajello L. Hyalohyphomycosis: a disease entity whose time has come. In: Newsletter: Medical Mycological Society of New York. 1982 20: 3-5
-
4
Ajello L, Georg L K, Steigbigel R T, Wang C JK.
A case of phaeohyphomycosis caused by a new species of Phialphora
.
Mycologia.
1974;
66
490-498
-
5
Revankar S G, Patterson J E, Sutton D A, Pullen R, Rinaldi M G.
Disseminated phaeohyphomycosis: review of an emerging mycosis.
Clin Infect Dis.
2002;
34
467-476
-
6
Dixon D M, Polak-Wyss A.
The medically important dematiaceous fungi and their identification.
Mycoses.
1991;
34
1-18
-
7 Sutton D A, Fethergill A W, Rinaldi M G. Mitosporic fungi: hyphomycetes: genus scedosporium. In: Mitchell CW Guide to Clinically Significant Fungi. Baltimore; Williams & Wilkins 1998: 358
-
8 St-Germain G, Summerbell R C.
Scedosporium
. In: Identifying Filamentous Fungi. 2nd ed. Belmont, CA; Blackwell Science 1996
-
9
Hironaga M, Watanabe S.
Annellated conidiogenous cells in Petriellidium boydii (Scedosporium apiospermum).
Sabouraudia.
1980;
18
261-268
-
10
De Hoog G S, Marvin-Sikkema F D, Lahpoor G A, Gottschall J C, Prins R A, Gueho E.
Ecology and physiology of the emerging opportunistic fungi Pseudallescheria boydii and Scedosporium prolificans
.
Mycoses.
1994;
37
71-78
, Erratum in: Mycoses 1994;37:223-l224
-
11
Liu K, Howell D N, Perfect J R, Schnell W A.
Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology.
Am J Clin Pathol.
1998;
109
45-54
-
12
Pefect J R, Schell W A.
The new fungal opportunists are coming.
Clin Infect Dis.
1996;
22
S112-S118
-
13
Ortoneda M, Pastor F J, Mayayo E, Guarro J.
Comparison of the virulence of Scedosporium prolificans strains from different origins in a murine model.
J Med Microbiol.
2002;
51
924-928
-
14
Jacobson E S.
Pathogenic roles for fungal melanins.
Clin Microbiol Rev.
2000;
13
708-717
-
15
Larcher G, Cimon B, Symoens F, Tonchin G, Chabasse D.
A 33 kDa serine proteinase from Scedosporium apiospermum
.
Biochem J.
1996;
315
119-126
-
16
Summerbell R C, Krajen S, Kane J.
Potted plants in hospitals as reservoirs of pathogenic fungi.
Mycopathologia.
1989;
106
13-22
-
17
Garcia-Pena E I, Hernandez S, Favela-Torres E et al..
Toluene biofiltration by the fungus Scediospermum apiospermum TB1.
Biotechnol Bioeng.
2001;
76
61-69
-
18
Claussen M, Schmidt S.
Biodegradation of phenylbenzoate and some of its derivatives by Scedosporium apiospermum
.
Res Microbiol.
1999;
150
413-420
-
19
Bereguer J, Rodriguez-Tudela J L, Richard C et al..
Deep infections caused by Scedosporium prolificans: a report on 16 cases in Spain and a review of the literature.
Medicine.
1997;
76
256-265
-
20
Slavin M A.
and the Australian Mycology Interest Group .
The epidemiology of candidaemia and mould infections in Australia.
J Antimicrob Chemo.
2002;
49(suppl 1)
3-6
-
21
Idigoras P, Perez-Trallero E, Pineiro L et al..
Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999.
Clin Infect Dis.
2001;
32
e158-e165
-
22
McNeil M M, Nash S L, Hajjeh R A et al..
Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.
Clin Infect Dis.
2001;
33
641-647
-
23
Castiglioni B, Sutton D A, Rinaldi M G, Fung J, Kusne S.
Pseudoallescheria boydii (anamorph Scedosporium apiospermum) infection in solid organ transplant recipients in a tertiary medical center and review of the literature.
Medicine.
2002;
81
333-348
-
24
Marr K A, Carter R A, Crippa F, Wald A, Corey L.
Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.
Clin Infect Dis.
2002;
34
909-917
-
25
Alvarez M, Lopez Ponga B, Rayon C et al..
Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients.
J Clin Microbiol.
1995;
33
3290-3295
-
26
Guerrero A, Torres P, Duran M T, Ruiz-Diez B, Rosales M, Rodriguez-Tudela J L.
Airborne outbreak of nosocomial Scedosporium prolificans infection.
Lancet.
2001;
357
1267-1268
-
27
Ruiz-Diaz B, Martin-Diez F, Rodriguez-Tudela J L et al..
Use of random amplification of polymorphic DNA (RAPD) and PCR-fingerprinting for genotyping a Scedopsorium prolificans (inflatum) outbreak in four leukemic patients.
Curr Microbiol.
1997;
35
186-190
-
28
Williamson E CM, Speers D, Arhur I H, Harnett G, Ryan G, Inglis T JJ.
Molecular epidemiology of Scedosporium apiospermum infection determined by PCR amplification of ribosomal intergenic spacer sequences in patients with chronic lung disease.
J Clin Microbiol.
2001;
39
47-50
-
29
Zouhair R, Defonatine A, Ollivier C et al..
Typing of Scedosporium apiospermum by multilocus enzyme electrophoresis and random amplification of polymorphic DNA.
J Med Microbiol.
2001;
50
925-932
-
30
Defontaine A, Zouhair R, Cimon B et al..
Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis.
J Clin Microbiol.
2002;
40
2108-2114
-
31
San Millan R, Quindos G, Garaizar J, Salesa R, Guarro J, Ponton J.
Characterization of Scedosporium prolificans clinical isolates by randomly amplified polymorphic DNA analysis.
J Clin Microbiol.
1997;
35
2270-2274
-
32
Wood G M, McCormack J G, Muir D B et al..
Clinical features of human infection with Scedosporium inflatum
.
Clin Infect Dis.
1992;
14
1027-1033
-
33
Wilson C M, O'Rourke E J, McGinnis M R, Salkin I F.
Scedosporium inflatum: clinical spectrum of a newly recognized pathogen.
J Infect Dis.
1990;
161
102-107
-
34
Chikhani L, Dupont B, Guilbert F, Improvisi L, Corre A, Bertrand J C.
Uncommon fungal maxillary sinusitis of dental origin due to Scedosporium prolificans
.
Rev Stomatol Chir Maxillofac.
1995;
96
66-69
-
35
Bloom S M, Warner R R, Weitzman I.
Maxillary sinusitis: isolation of Scedosporium (Monosporium) apiospermum, anamorph of Petrellidium (Allescheria) boydii
.
Mt Sinai J Med.
1982;
49
492-494
-
36
Machado C M, Martins M A, Heins-Vaccari E M et al..
Scedosporium apiospermum sinusitis after bone marrow transplantation: report of a case.
Rev Inst Med Trop Sao Paulo.
1998;
40
321-323
-
37
Machado C M, Martins M A, Heins-Vaccari E M et al..
Scedosporium apiospermum sinusitis after bone marrow transplantation: report of a case.
Rev Inst Med Trop Sao Paulo.
1998;
40
321-323
-
38
Eckburg P B, Zolopa A R, Montoya J G.
Invasive fungal sinusitis due to Scedosporium apiospermum in a patient with AIDS.
Clin Infect Dis.
1999;
29
212-213
-
39
Cimon B, Carrere J, Vinatier J F et al..
Clinical significance of Scedosporium apiospermum in cystic fibrosis.
Eur J Clin Microbiol Infect Dis.
2000;
19
53-56
-
40
Del Palacio A, Garau M, Amor E et al..
Case reports: transient colonization with Scedosporium prolificans: report of four cases in Madrid.
Mycoses.
2001;
44
321-325
-
41
Lake F R, Tribe A E, McAleer R, Froudist J, Thompson P J.
Mixed allergic bronchopulmonary fungal disease due to Pseudallescheria boydii and Aspergillus
.
Thorax.
1990;
45
489-491
-
42
Travis L B, Roberts G D, Wilson W R.
Clinical significance of Pseudallescheria boydii: a review of 10 years' experience.
Mayo Clin Proc.
1985;
60
531-537
-
43
Al Refai M, Duhamel C, Le Rochais J P, Icard P.
Lung scedosporiasis: a differential diagnosis of aspergillosis.
Eur J Cardiothorac Surg.
2002;
21
938-999
-
44
Greig J R, Khan M A, Hopkinson N S et al..
Pulmonary infection with Scedosporium prolificans in an immunocompetent individual.
J Infect.
2001;
43
15-17
-
45
Jabado N, Casanova J L, Haddad E et al..
Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease.
Clin Infect Dis.
1998;
27
1437-1441
-
46
Phillips P, Forbes J C, Speert D P.
Disseminated infection with Pseudallescheria boydii in a patient with chronic granulomatous disease: response to gamma-interferon plus antifungal chemotherapy.
Pediatr Infect Dis J.
1991;
10
536-539
-
47
Rollot F, Blanche P, Richaud-Thiriez B et al..
Pneumonia due to Scedosporium apiospermum in a patient with HIV infection.
Scand J Infect Dis.
2000;
32
439
-
48
Zaas D.
Cases from the Osler Medical Service at Johns Hopkins University: Scedosporium apiospermum mycetoma of the lung.
Am J Med.
2002;
113
760-762
-
49
Tekavec J, Mlinaric-Missoni E, Babic-Vazic V.
Pulmonary tuberculosis associated with invasive pseudallescheriasis.
Chest.
1997;
111
508-511
-
50
Murayama T, Amitani R, Tsuyuguchi K et al..
Polypoid bronchial lesions due to Scedosporium apiospermum in a patient with Mycobacterium avium complex pulmonary disease.
Eur Respir J.
1998;
12
745-747
-
51
Jahagirdar B N, Morrison V A.
Emerging fungal pathogens in patients with hematologic malignancies and marrow/stem-cell transplant recipients.
Semin Respir Infect.
2002;
17
113-120
-
52
Khurshid A, Barnett T, Sekosan M, Ginzburg A S, Onal E.
Disseminated Pseudallescheria boydii infection in a nonimmunocompromised host.
Chest.
1999;
116
572-574
-
53
Tamm M, Malouf M, Glanville A.
Pulmonary Scedosporium infection following lung transplantation.
Transpl Infect Dis.
2001;
3
189-194
-
54
Talbot T R, Hatcher J, Davis S F, Pierson R N, Barton R, Dummer S.
Scedosporium apiospermum pneumonia and sternal wound infection in a heart transplant recipient.
Transplantation.
2002;
74
1645-1647
-
55
Baddley J W, Stroud T P, Salzman D, Pappas P G.
Invasive mold infections in allogeneic bone marrow transplant recipients.
Clin Infect Dis.
2001;
32
1319-1324
-
56
Spielberger R T, Tegtmeier B R, O'Donnell M R et al..
Fatal Scedosporium prolificans (S. inflatum) fungemia following allogeneic bone marrow transplantation: report of a case in the United States.
Clin Infect Dis.
1995;
21
1067
-
57
Salesa R, Burgos A, Ondiviela R, Richard C, Quindos G, Ponton J.
Fatal disseminated infection by Scedosporium inflatum after bone marrow transplantation.
Scan J Infect Dis.
1993;
25
389-393
-
58
Garcia-Arata M I, Otero M J, Zomeno M, de la Figuera M A, de las Cueva M C, Lopez-Brea M.
Scedosporium apiospermum pneumonia after autologous bone marrow transplantation.
Eur J Clin Microbiol Infect Dis.
1996;
15
600-603
-
59
Sparrow S A, Hallam L A, Wild B E, Baker D L.
Scedosporium inflatum: first case report of disseminated infection and review of the literature.
Pediatr Hematol Oncol.
1992;
9
293-295
-
60
Ruchel R, Wilichowski E.
Cerebral Pseudallescheria mycosis after near-drowning.
Mycoses.
1995;
38
473-475
-
61
Kershaw P, Freeman R, Templeton D et al..
Pseudallescheria boydii infection of the central nervous system.
Arch Neurol.
1990;
47
468-472
-
62
Dworzack D L, Clark R B, Borkowski W J et al..
Pseudallescheria boydii brain abscess: association with near-drowning and efficacy of high-dose, prolonged miconazole therapy in patients with multiple abscesses.
Medicine.
1989;
68
218-224
-
63
Fietz T, Knauf W, Schwartz S, Thiel E.
Intramedullary abscess in a patient with disseminated Scedosporium apiospermum infection.
Br J Haematol.
2003;
120
724
-
64
Madrigal V, Alonso J, Bureo E, Figols F J, Salesa R.
Fatal meningoencephalitis cause by Scedosporium inflatum (Scedosporium prolificans) in a child with lymphoblastic leukemia.
Eur J Clin Microbiol Infect Dis.
1995;
14
601-603
-
65
Kleinschmidt-DeMasters B K.
Central nervous system aspergillosis: a 20-year retrospective series.
Hum Pathol.
2002;
33
116-124
-
66
Gari M, Fruit J, Rousseaux P et al..
Scedosporium (Monosporium) apiospermum: multiple brain abscesses.
Sabouraudia.
1985;
23
371-376
-
67
Watanabe S, Hironaga M.
An atypical isolate of Scedosporium apiospermum from a purulent meningitis in man.
Sabouraudia.
1981;
19
209-215
-
68
Nenoff P, Gutz U, Tintelnot K et al..
Disseminated mycosis due to Scedosporium prolificans in an AIDS patient with Burkitt lymphoma.
Mycoses.
1996;
39
461-465
-
69
Safdar A, Papadopoulos E B, Young J W.
Breakthrough Scedosporium apiospermum (Pseudallescheria boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high-risk allogeneic hematopoietic stem cell transplantation: scedosporiosis and recent advances in antifungal therapy.
Transpl Infect Dis.
2002;
4
212-217
-
70
Nesky M A, McDougal E C, Peacock J E.
Pseudallescheria boydii brain abscess successfully treated with coriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis.
Clin Infect Dis.
2000;
31
673-677
-
71
Saccardo P A.
In Notae Mycologicae, Series XIII.
Ann Mycol.
1911;
9
254-255
-
72
Shear C L.
Life history of an undescribed Ascomycete isolated from a granular mycetoma of man.
Mycologia.
1922;
14
239-243
-
73
Emmons C W.
Allescheria boydii and Monosporium apiospermum
.
Mycologica.
1944;
36
188-193
-
74
Castro L G, Belda J W, Salebian A, Cuce L C.
Mycetoma: a retrospective study of 41 cases seen in Sao Paulo, Brazil, from 1978 to 1989.
Mycoses.
1993;
36
89-95
-
75
Miyamoto T, Sasaoka R, Kawaguchi M et al..
Scedosporium apiospermum skin infection: a case report and review of the literature.
J Am Acad Dermatol.
1998;
39
498-500
-
76
Severo L C, Oliveira FdeM, Londero A T.
Subcutaneous scedosporiosis: report of two cases and review of the literature.
Rev Inst Med Trop Sao Paulo.
1997;
39
227-230
-
77
Liu Y F, Zhao X D, Ma C L, Li C X, Zhang T S, Liao W J.
Cutaneous infection by Scedosporium apiospermum and its successful treatment with itraconazole.
Clin Exp Dermatol.
1997;
22
198-200
-
78
Gillum P S, Gurswami A, Taira J W.
Localized cutaneous infection by Scedosporium prolificans (inflatum).
Int J Dermatol.
1997;
36
297-299
-
79
Bower C PR, Oxley J D, Campbell C K, Archer C B.
Cutaneous Scedosporium apiospermum infection in an immunocompromised patient.
J Clin Pathol.
1999;
52
846-848
-
80
Bosma F, Voss A, van Hamersvelt H W et al..
Two cases of subcutaneous Scedosporium apiospermum infection treated with voriconazole.
Clin Microbiol Infect.
2003;
9
750-753
-
81
Chaveiro M A, Vieira R, Cardoas J, Afonso A.
Cutaneous infection due to Scedosporium apiospermum in an immunosuppressed patient.
J Eur Acad Dermatol Venereol.
2003;
17
47-49
-
82
Gompels M M, Bethune C A, Jackson G, Spickett G P.
Scedosporium apiospermum in chronic granulomatous disease treated with an HLA matched bone marrow transplant.
J Clin Pathol.
2002;
55
784-786
-
83
Canet J J, Pagerols C, Sanchez P et al..
Lymphocutaneous syndrome due to Scedosporium apisospermum
.
Clin Microbiol Infect.
2001;
7
648-652
-
84
Kushara M, Hachisuka H.
Lymphocutaneous infection due to Scedosporium apiospermum
.
Int J Dermatol.
1997;
36
684-688
-
85
Torok L, Simon G, Csornai A, Tapai M, Torok I.
Scedosporium apiospermum infection imitating lymphocutaneous sporotrichosis in a patient with myeloblastic-monocytic leukaemia.
Br J Dermatol.
1995;
133
805-809
-
86
Hagari Y.
Cutaneous infection showing sporotrichoid spread caused by Pseudallescheria boydii (Scedosporium apiospermum): successful detction of fungal DNA in formalin-fixed, paraffin-embedded sections by seminested PCR.
Arch Dermatol.
2002;
138
271-272
-
87
Kiraz N, Gulbas Z, Akgun Y, Uzun O.
Lymphadenitis caused by Scedosporium apiospermum in an immunocompetent patient.
Clin Infect Dis.
2001;
32
e59-e61
-
88
Ochiai N, Shimazaki C, Uchida R et al..
Disseminated infection due to Scedosporium apiospermum in a patient with acute myelogenous leukemia.
Leuk Lymphoma.
2003;
44
369-372
-
89
Miyamoto T, Sasaoka R, Kawaguchi M et al..
Scedosporium apiospermum skin infection. A case report and review of the literature.
J Am Acad Dermatol.
1998;
39
498-500
-
90
Malloch D, Salkin I F.
A new species if Scedosporium associated with osteomyelitis in humans.
Mycotaxon.
1984;
21
247-255
-
91
Ginter G, de Hoog G S, Pschaid A et al..
Arthritis without grains caused by Pseudallescheria boydii
.
Mycoses.
1995;
38
369-371
-
92
Dellestable F, Kures L, Mainard D, Pere P, Gaucher A.
Fungal arthritis due to Pseudallescheria boydii (Scedosporium apiospermum).
J Rheumatol.
1994;
21
766-768
-
93
Gatto J D, Paterson L, Davis L, Lockwood L, Allworth A.
Vertebral osteomyelitis due to Pseudallescheria boydii
.
Pathology.
1997;
29
238-240
-
94
Malekzadeh M, Overturf G D, Auerbach S B, Wong L, Horsch M.
Chronic, recurrent osteomyelitis caused by Scedosporium inflatum
.
Pediatr Infect Dis J.
1990;
9
357-359
-
95
Levine N B, Kurokawa R, Fichtenbaum C J, Howington J A, Kuntz C.
An immunocompetent patient with primary Scedosporium apiospermum vertebral osteomyelitis.
J Spinal Discord Tech.
2002;
15
425-430
-
96
Le Gouill S L, Morineau N, Miegeville M, Milipied N, Harousseau J L, Moreau P.
Pseudallescheria boydii osteoarthritis in a patient with acute lymphoblastic leukemia: a case report.
Rev Med Interne.
1999;
20
434-438
-
97
Tirado-Miranda R, Solera-Santos J, Brasero J C, Haro-Estarriol M, Cascales-Sanchez P, Igualada J B.
Septic arthritis due to Scedosporium apiospermum: case report and review.
J Infect.
2001;
43
210-212
-
98
Kumar B, Crawford G J, Morlet G C.
Scedosporium prolificans corneoscleritis: a successful outcome.
Aust N Z J Ophthalmol.
1997;
25
169-171
-
99
Ksiazek S M, Morris D A, Mandelbaum S, Rosenbaum P S.
Fungal panophthalmitis secondary to Scedosporium apiospermum (Pseudallescheria boydii) keratitis.
Am J Ophthalmol.
1994;
118
531-533
-
100
Sullivan L J, Snibson G, Joseph C, Taylor H R.
Scedosporium prolificans sclerokeratitis.
Aust N Z J Ophthalmol.
1994;
22
207-209
-
101
Moriarty A P, Crawford G J, McAllister I L, Constable I J.
Severe corneoscleral infection: a complication of beta irradiation scleral necrosis following pterygium excision.
Arch Ophthalmol.
1993;
111
947-951
-
102
Diaz-Valle D, Benitez del Castillo J M, Amor E et al..
Severe keratomycosis secondary to Scedosporium apiospermum
.
Cornea.
2002;
21
516-518
-
103
Wu Z, Ying H, Yiu S, Irvine J, Smith R.
Fungal keratitis caused by Scedosporium apiospermum
.
Cornea.
2002;
21
519-523
-
104
Taylor A, Wiffen S J, Kennedy C J.
Post-traumatic Scedosporium inflatum endophthalmitis.
Clin Experiment Ophthalmol.
2002;
30
47-48
-
105
Arthur S, Steed L L, Apple D J, Peng Q, Howard G, Escobar-Gomez M.
Scedosporium prolificans keratouveitis in association with a contact lens retained intraocularly over a long term.
J Clin Microbiol.
2001;
39
4579-4582
-
106
Guarro J, Gene J.
Acrophialophora fusispora misidentified as Scedosporium prolificans
.
J Clin Microbiol.
2002;
40
3544-3545
-
107
McKelvie P A, Wong E YH, Chow L PC, Hall A JH.
Scedosporium endophthalmitis: two fatal disseminated cases of Scedosporium infection presenting with endophthalmitis.
Clin Experiment Ophthalmol.
2001;
29
330-334
-
108
Kirath H, Uzun O, Kiraz N, Eldem B.
Scedosporium apiospermum chorioretinitis.
Acta Ophthalmol Scand.
2001;
79
540-542
-
109
Jones J, Katz S E, Lubow M.
Scedosporium apiospermum of the orbit.
Arch Ophthalmol.
1999;
117
272-273
-
110
Westerman D A, Speed B R, Prince H M.
Fatal disseminated infection by Scedosporium prolificans during induction therapy for acute leukemia: a case report and literature review.
Pathology.
1999;
31
393-394
-
111
Raj R, Frost A E.
Scedosporium apiospermum fungemia in a lung transplant recipient.
Chest.
2002;
121
1714-1716
-
112
Sobottka I, Deneke J, Pothmann W, Heinemann A, Mack D.
Fatal native valve endocarditis due to Scedosporium apiospermum (Pseudallescheria boydii) following trauma.
Eur J Clin Microbiol Infect Dis.
1999;
18
387-389
-
113
Toy E C, Rinaldi M G, Savitch C B, Leibovitch E R.
Endocarditis and hip arthritis associated with Scedosporium inflatum
.
South Med J.
1990;
83
957-960
-
114
Carreter de Granda M E, Richard C, Conde E et al..
Endocarditis caused by Scedosporium prolificans after autologous peripheral blood stem cell transplantation.
Eur J Clin Microbiol Infect Dis.
2001;
20
215-217
-
115
Watson J C, Myseros J S, Bullock M R.
True fungal mycotic aneurysm of the basilar artery: a clinical and surgical dilemma.
Cerebrovasc Dis.
1999;
9
50-53
-
116
Ben Hamida M, Bedrossian J, Pruna A, Fouqueray B, Meticier F, Idatte J M.
Fungal mycotic aneurysms and visceral infection due to Scedosporium apiospermum in a kidney transplant patient.
Transplant Proc.
1993;
25
2290-2291
-
117
O'Bryan T A, Browne F A, Schonder J F.
Scedosporium apiospermum (Pseudallescheria boydii) endocarditis.
J Infect.
2002;
44
189-192
-
118
Yao M, Messner A H.
Fungal malignant otitis externa due to Scedosporium apiospermum
.
Ann Otol Rhinol Laryngol.
2001;
110
377-380
-
119
Kimura M, McGinnis M R.
Fontana-Masson-stained tissue from culture-proven mycoses.
Arch Pathol Lab Med.
1998;
122
1107-1111
-
120
Pinto M R, Mulloy B, Haido R M et al..
A peptidorhamnomannan from the mycelium of Pseudallescheria boydii is a potential diagnostic antigen of this emerging human pathogen.
Microbiology.
2001;
147
1499-1506
-
121
Wedde M, Muller D, Tintelnot K, De Hoog G S, Stahl U.
PCR-based identification of clinically relevant Pseudallescheria/Scedosporium strains.
Med Mycol.
1998;
36
61-67
-
122
Najvar L K, Boacnegra R, Hernandez S, Graybill J R.
Comparison of quantitative PCR (qPCR) and semi-quantitative culture (CFU) for measuring tissue burden of Scedosporium prolificans and Pseudallescheria boydii in a murine model.
ICAAC International Conference for Antimicrobial Agents and Chemotherapy.
2003;
, Abstract #M-367
-
123
Sutton D A.
Laboratory evaluation of new antifungal agents against rare and refractory mycoses.
Curr Opin Infect Dis.
2002;
15
575-582
-
124 Sutton DA, Fothergill AW, Rinaldi MG Guide to Clinically Significant Fungi. Baltimore; Williams & Wilkins 1998
-
125
Meletiadis J, Meis J FGM, Mouton J, Rodriguez-Tudela J L, Donelly J P, Verweij P E.
In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates.
Antimicrob Agents Chemother.
2002;
46
62-68
-
126
Espinel-Ingroff A.
Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.
J Clin Microbiol.
1998;
36
2950-2956
-
127
Del Poeta M, Schell W A, Perfect J R.
In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds.
Antimicrob Agents Chemother.
1997;
41
1835-1836
-
128
Perfect J R, Marr K A, Walsh T J et al..
Voriconazole treatment for less-common, emerging, or refractory fungal infections.
Clin Infect Dis.
2003;
36
1122-1131
-
129
Meletiadis J, Mouton J W, Meis J F, Verweij P E.
Combination chemotherapy for the treatment of invasive infections by Scedosporium prolificans
.
Clin Microbiol Infect.
2000;
6
336-337
-
130
Gosbell I B, Toumasatos V, Yong J, Kuo R S, Ellis D H, Perrie R C.
Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery.
Mycoses.
2003;
46
233-236
-
131
McGinnis M R, Pasarell L.
In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi.
Med Mycol.
1998;
36
243-246
-
132
Meletiadis, Mouton J W, Meis J FGM, Verweij P E.
In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.
Antimicrob Agents Chemother.
2003;
47
106-117
-
133
Howden B P, Slavin M A, Schwarer A P et al..
Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.
Eur J Clin Microbiol Infect Dis.
2003;
22
111-113
-
134
Bouza E, Munoz P, Vega L et al..
Clinical resolution of Scedosporium prolificans fungemia associated with reversal of neutropenia following administration of granulocyte colony-stimulating factor.
Clin Infect Dis.
1996;
23
192-193
-
135
Nulens E, Eggink C, Rijs A JMM, Wesseling P, Verweij P E.
Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole.
J Clin Microbiol.
2003;
41
2261-2264
-
136
Lai T F, Malhotra R, Esmail-Zaden R et al..
Use of voriconazole in Scedosporium apiospermum keratitis.
Cornea.
2003;
22
391-392
-
137
Saracli M A, Erdem U, Gonlum A, Yildiran S T.
Scedosporium apiospermum keratitis treated with itraconazole.
Med Mycol.
2003;
41
111-114
-
138
Steinbach W J, Schell W A, Miller J L, Perfect J R.
Scedosporium prolificans osteomyelitis in a immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide.
J Clin Microbiol.
2003;
41
3981-3985
-
139
Patterson J E, Peters J, Calhoon J H et al..
Investigation and control of aspergillosis and other filamentous fungal infections in solid-organ transplant recipients.
Transpl Infect Dis.
2000;
2
22-28
-
140
Simarro E, Marin F, Morales A, Sanz E, Perez J, Ruiz J.
Fungemia due to Scedosporium prolificans: a description of two cases with fatal outcome.
Clin Microbiol Infect.
2001;
7
645-647
-
141
Centers for Disease Control and Prevention (CDC) .
Guidelines for environmental infection control in healthcare facilities: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
MMWR Morb Mortal Wkly Rep.
2003;
52
1-42
Kieren MarrM.D.
Fred Hutchinson Cancer Research Center, University of Washington
Seattle, 1100 Fairview Ave. N. D3-100
Seattle, WA 98109-1024
Email: kmarr@fhcrc.org
